Q&A: Gilead public affairs chief on new strategy, TikTok, and why the company won’t ‘keep doing things the same way’ 

After years of quiet focus on HIV and virology and stoic responses to flare-ups of attention over its pricing decisions, the new Gilead Sciences is ready to talk.

It’s got a revamped public affairs strategy that favors proactivity and aims to own the company’s narrative as it moves into oncology…
Click here to view original post